About Shield

OUR COMPANY IN NUMBERS

Lorem ipsum dolor sit amet

0
Mauris accumsan

Duis dignissim mi ut laoreet mollis. Nunc id tellus justo finibus eleifend justo.

0
Massa libero

Duis dignissim mi ut laoreet mollis. Nunc id tellus justo finibus eleifend justo.

0
Dignissim

Duis dignissim mi ut laoreet mollis. Nunc id tellus justo finibus eleifend justo.

0
Eleifend justo

Duis dignissim mi ut laoreet mollis. Nunc id tellus justo finibus eleifend justo.

The idea of developing a solution for breast cancer risk analysis and the diagnosis was formed by the leader of the Shield team (Dr Mahdi Dodangeh, PhD in Mathematics and Data Scientist) after losing one close relative for the late diagnosis of breast cancer. She could easily cure if diagnosed in early stages, but late diagnosis could not save her as the cancer molecules spread already in various organs. 

Therefore, Mahdi contacted various hospitals, in order to find related data and tried to find a solution for early detection of breast cancer. With the help of MD Ghodsirad (specialists in Radiology and nuclear medicine) and MD Zeinab Gholami Bardeji (specialist in Radiology and woman imaging), he managed to make the first product. The team is now Working hard to release the first version of the Shield App globally.

Spread the message of Shield around the globe to fight breast cancer and save as many life as possible.

Mahdi Dodangeh
CEO & Co-Founder Of Shield

OUR COMPANY IN NUMBERS

Lorem ipsum dolor sit amet

James Brandon

Fusce ut velit laoreet, tempus arcu eu, molestie tortor. Nam vel justo cursus, faucibus.

Jessica Borska

Fusce ut velit laoreet, tempus arcu eu, molestie tortor. Nam vel justo cursus, faucibus.

Michael Boston

Fusce ut velit laoreet, tempus arcu eu, molestie tortor. Nam vel justo cursus, faucibus.

Anna Wosak

Fusce ut velit laoreet, tempus arcu eu, molestie tortor. Nam vel justo cursus, faucibus.

Shield MISSION AND VISION 

The vision of the company is to be among the leading global providers of automated cancer prediction systems using AI. The company was created aiming to become a top key-player in the healthcare market value chain and a trusted solution to early detection of breast cancer. Our final products will inevitably have impacts on the social and healthcare system by reducing the costs of treating breast cancer in the early stages. Our mission is to provide comprehensive, non-invasive, and highly accuracy-efficient solutions to detect risks of developing breast cancer by starting from the pre-diagnosis stage as well as providing best recommendation and advices to improve the survival rate of patients.